Jump to content

AS04

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Shaded0 (talk | contribs) at 16:20, 13 August 2017 (→‎top: clean up, typo(s) fixed: Furthermore → Furthermore, using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

AS04 (Aka. "Adjuvant System 04") is a trade name for combination of adjuvants used in various vaccine product by GlaxoSmithKline (GSK), in particular the Fendrix Hepatitis B vaccine. It consists of aluminum hydroxide and monophosphoryl lipid A (MPL). Furthermore, it is the successor of AS03 which is a Squalene based adjuvant approved for pandemic vaccine by the EMA.[1]

References

  1. ^ Plotkin; et al. Vaccines 6th ed. Elsevier Saunders. pp. 58–79. ISBN 978-1-4557-0090-5.

See also


Stub icon

This biochemistry article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=AS04&oldid=795339011"